261 related articles for article (PubMed ID: 38519057)
1. Advances and challenges in cancer immunoprevention and immune interception.
Stanton SE; Castle PE; Finn OJ; Sei S; Emens LA
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38519057
[TBL] [Abstract][Full Text] [Related]
2. NCI Resources for Cancer Immunoprevention Research.
Sei S; Srivastava S; Kelly HR; Miller MS; Leitner WW; Shoemaker RH; Szabo E; Castle PE
Cancer Immunol Res; 2024 Apr; 12(4):387-392. PubMed ID: 38562082
[TBL] [Abstract][Full Text] [Related]
3. Transforming Cancer Prevention through Precision Medicine and Immune-oncology.
Kensler TW; Spira A; Garber JE; Szabo E; Lee JJ; Dong Z; Dannenberg AJ; Hait WN; Blackburn E; Davidson NE; Foti M; Lippman SM
Cancer Prev Res (Phila); 2016 Jan; 9(1):2-10. PubMed ID: 26744449
[TBL] [Abstract][Full Text] [Related]
4. Precancer Atlas to Drive Precision Prevention Trials.
Spira A; Yurgelun MB; Alexandrov L; Rao A; Bejar R; Polyak K; Giannakis M; Shilatifard A; Finn OJ; Dhodapkar M; Kay NE; Braggio E; Vilar E; Mazzilli SA; Rebbeck TR; Garber JE; Velculescu VE; Disis ML; Wallace DC; Lippman SM
Cancer Res; 2017 Apr; 77(7):1510-1541. PubMed ID: 28373404
[TBL] [Abstract][Full Text] [Related]
5. Cancer Immunoprevention: Current Status and Future Directions.
Keshavarz-Fathi M; Rezaei N
Arch Immunol Ther Exp (Warsz); 2021 Feb; 69(1):3. PubMed ID: 33638703
[TBL] [Abstract][Full Text] [Related]
6. Moving Immunoprevention Beyond Virally Mediated Malignancies: Do We Need to Link It to Early Detection?
Dhodapkar MV; Dhodapkar KM
Front Immunol; 2019; 10():2385. PubMed ID: 31649683
[TBL] [Abstract][Full Text] [Related]
7. Cancer immunoprevention: a new approach to intercept cancer early.
Umar A
Cancer Prev Res (Phila); 2014 Nov; 7(11):1067-71. PubMed ID: 25237055
[TBL] [Abstract][Full Text] [Related]
8. Immunoprevention of Pancreatic Cancer.
Rao CV; Mohammed A; Asch AS; Janakiram NB
Curr Med Chem; 2018; 25(22):2576-2584. PubMed ID: 28240168
[TBL] [Abstract][Full Text] [Related]
9. Worth a Pound of Cure? Emerging Strategies and Challenges in Cancer Immunoprevention.
Haldar SD; Vilar E; Maitra A; Zaidi N
Cancer Prev Res (Phila); 2023 Sep; 16(9):483-495. PubMed ID: 37001882
[TBL] [Abstract][Full Text] [Related]
10. New target antigens for cancer immunoprevention.
Lollini PL; Nicoletti G; Landuzzi L; De Giovanni C; Nanni P
Curr Cancer Drug Targets; 2005 May; 5(3):221-8. PubMed ID: 15892621
[TBL] [Abstract][Full Text] [Related]
11. Vaccination-Based Immunoprevention of Colorectal Tumors: A Primer for the Clinician.
Jackson K; Samaddar S; Markiewicz MA; Bansal A
J Clin Gastroenterol; 2023 Mar; 57(3):246-252. PubMed ID: 36730670
[TBL] [Abstract][Full Text] [Related]
12. Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision.
Emens LA; Romero PJ; Anderson AC; Bruno TC; Capitini CM; Collyar D; Gulley JL; Hwu P; Posey AD; Silk AW; Wargo JA
J Immunother Cancer; 2024 Jun; 12(6):. PubMed ID: 38901879
[TBL] [Abstract][Full Text] [Related]
13. AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public Health.
Lippman SM; Abate-Shen C; Colbert Maresso KL; Colditz GA; Dannenberg AJ; Davidson NE; Disis ML; DuBois RN; Szabo E; Giuliano AR; Hait WN; Lee JJ; Kensler TW; Kramer BS; Limburg P; Maitra A; Martinez ME; Rebbeck TR; Schmitz KH; Vilar E; Hawk ET
Cancer Prev Res (Phila); 2018 Dec; 11(12):735-778. PubMed ID: 30530635
[TBL] [Abstract][Full Text] [Related]
14. Emerging Trends in Cancer Prevention Agent Development.
Miller MS; Mohammed A
J Cancer Prev; 2023 Mar; 28(1):24-28. PubMed ID: 37033328
[TBL] [Abstract][Full Text] [Related]
15. Cancer immunoprevention--the next frontier.
Smit MA; Jaffee EM; Lutz ER
Cancer Prev Res (Phila); 2014 Nov; 7(11):1072-80. PubMed ID: 25245763
[TBL] [Abstract][Full Text] [Related]
16. National Cancer Institute Think-Tank Meeting Report on Proteomic Cartography and Biomarkers at the Single-Cell Level: Interrogation of Premalignant Lesions.
Kagan J; Moritz RL; Mazurchuk R; Lee JH; Kharchenko PV; Rozenblatt-Rosen O; Ruppin E; Edfors F; Ginty F; Goltsev Y; Wells JA; LaCava J; Riesterer JL; Germain RN; Shi T; Chee MS; Budnik BA; Yates JR; Chait BT; Moffitt JR; Smith RD; Srivastava S
J Proteome Res; 2020 May; 19(5):1900-1912. PubMed ID: 32163288
[TBL] [Abstract][Full Text] [Related]
17. TIME for Bugs: The Immune Microenvironment and Microbes in Precancer.
Borthwick Bowen M; Helmink BA; Wargo JA; Yates MS
Cancer Prev Res (Phila); 2023 Sep; 16(9):497-505. PubMed ID: 37428011
[TBL] [Abstract][Full Text] [Related]
18. From Premalignant Biology to Precision Interception: Connecting the Dots with a Curated Collection of Invited Articles.
Colbert Maresso K; Maitra A; Hawk ET; Vilar E
Cancer Prev Res (Phila); 2023 Jul; 16(7):365-367. PubMed ID: 37403656
[TBL] [Abstract][Full Text] [Related]
19. Cancer immunoprevention.
Finn OJ; Beatty PL
Curr Opin Immunol; 2016 Apr; 39():52-8. PubMed ID: 26799207
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous Squamous Cell Carcinoma: The Frontier of Cancer Immunoprevention.
Chang MS; Azin M; Demehri S
Annu Rev Pathol; 2022 Jan; 17():101-119. PubMed ID: 35073167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
